By Jack Bradley, Staff Writer On February 14, Verax Biomedical Inc. filed an antitrust suit in federal court against the American Red Cross (“ARC”) alleging that it had used its position within the blood transfusion market to monopolize platelet treatment.[1] Verax also alleged that ARC published false statements about Verax’s […]
By: Mia Hoetzlein-Sirman, Staff Writer The Affordable Care Act, colloquially known as Obamacare, is currently facing a challenge as Kelley v. Becerra, which calls into question the legality of the preventative care provision of the Act, sits in front of a federal judge in Texas. The provision ensures that preventative […]
By Drew Rummel, Staff Writer If you remember anything you have heard recently about Hillary Clinton, it is most likely something that has to do with her emails. We have heard all kinds of biased statements from various mainstream media outlets. We have heard the Donald Trump campaign repeatedly […]
By David Zvirman, Staff Writer The news of the $85.4 billion purchase of Time Warner by AT&T has brought considerable speculation of how the deal will impact consumers and whether it should be approved by federal regulators.[1] There are also other important questions to ask, however. Who are these […]
